Coronavirus (COVID-19): Important Information From Scripps Learn more

Third Annual Scripps Cardiomyopathy and Cardio-Oncology Symposium: A Case-Based Approach

Join us September 26, 2020 in San Diego!

Expert faculty will cover a wide range of topics including the diagnosis, management, and state-of-the-art treatment for hypertrophic cardiomyopathy, chemo-induced cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, arrhythmias related to each of these diseases, genetic abnormalities that can lead to these diseases, and advanced cardiac imaging. 

Conference Location

San Diego Mission Bay Resort

1775 E Mission Bay Drive

San Diego, California 92109

Reserve a discounted room

Conference Details

Course Overview

The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to cardiomyopathy and cardiovascular health of cancer survivors. Cardio-oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular toxicities. Similarly cardiac amyloidosis is a burgeoning disease with exciting new treatments. The program is intended for those involved in the care of patients with cardiomyopathies, diastolic heart failure, chemotherapy or radiation induced heart disease, pulmonary hypertension, and cardiomyopathy related arrhythmic diseases.

Nationally recognized faculty will cover challenging heart failure topics related to common cardiomyopathies, role of hemodynamic testing, latest structural heart therapies, ventricular assist devices and transplantation, cardio-oncology, cardiac imaging, electrophysiology, and genomics. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.

Educational Objectives

After attending this live activity, participants should be able to:

  • Assess the risks of oncologic treatment-related cardiac dysfunction for patients who have undergone therapy for cancer.
  • Implement strategies for early detection, correction of cardiac risk factors, and close and long-term cardiac monitoring in order to reduce the effects of cardiotoxicity for patients who are at risk of cancer treatment-related cardiac dysfunction, including heart failure, valvular dysfunction and autonomic dysfunction.
  • Recognize potential cardiovascular complications of novel molecular targeted therapies, including arrhythmias, cardiomyopathy, cardiac ischemia, and hypertension.
  • Critically evaluate multi-modality imaging such as cardiac magnetic resonance (MR), echocardiography, and nuclear imaging including positron emission tomography (PET) scanning in the diagnosis and follow-up of cardiomyopathy.
  • Describe patient selection for advanced diagnostics for dyspnea.
  • Identify common clinical and diagnostic criteria that would prompt a detailed pulmonary hypertension evaluation.
  • Apply recommendations from the recently updated ACC/AHA/Heart Failure Society of America (HFSA) guidelines when diagnosing and managing patients with cardiomyopathy.
  • Discuss the latest diagnosis and treatment options available for cardiac amyloidosis.
  • Incorporate guidelines and algorithms for the evaluation and management of patients with syncope, sudden cardiac death, and cardiac sarcoidosis based on current recommendations from the ACC/AHA/Heart Rhythm Society (HRS).
  • Evaluate available clinical evidence for recommendations for the management of cardiovascular disease during pregnancy.
  • Identify patients who would benefit from implantable pulmonary artery sensor monitoring.
  • Illustrate the importance of the multidisciplinary cardio-oncology team.

Accreditation and Disclosures


Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Commercial Support

This course is supported, in part, by educational grants from industry, in accordance with ACCME Accreditation Standards for Commercial Support. Appropriate acknowledgement will be given to all supporters at the time of the educational activity.

Cultural and Linguistic Competency

This activity is in compliance with California Assembly Bill 1195, which requires that all CME activities comprising a patient care element include curriculum addressing the topic of cultural and linguistic competency. The intent of this bill is to ensure that health care professionals are able to meet the cultural and linguistic concerns of a diverse patient population through effective and appropriate professional development. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area. A variety of resources are available that address cultural and linguistic competency, some of which can be found in the Cultural & Linguistic Competency Resource Guide.

Event details

San Diego Mission Bay Resort
1775 E Mission Bay Drive
San Diego, CA 92109
Get directions
Date and time

Sat, Sep 26th, 2020

7 am - 4:30 pm